ATE238335T1 - 5' deoxycytidin-derivative - Google Patents

5' deoxycytidin-derivative

Info

Publication number
ATE238335T1
ATE238335T1 AT99907492T AT99907492T ATE238335T1 AT E238335 T1 ATE238335 T1 AT E238335T1 AT 99907492 T AT99907492 T AT 99907492T AT 99907492 T AT99907492 T AT 99907492T AT E238335 T1 ATE238335 T1 AT E238335T1
Authority
AT
Austria
Prior art keywords
deoxycytidine derivatives
deoxycytidine
derivatives
Prior art date
Application number
AT99907492T
Other languages
English (en)
Inventor
Kazuo Hattori
Tohru Ishikawa
Hideo Ishitsuka
Yasunori Kohchi
Nobuhiro Oikawa
Nobuo Shimma
Hitomi Suda
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE238335T1 publication Critical patent/ATE238335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99907492T 1998-02-06 1999-02-03 5' deoxycytidin-derivative ATE238335T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98102080 1998-02-06
EP98108321 1998-05-07
PCT/EP1999/000710 WO1999040099A1 (en) 1998-02-06 1999-02-03 5'-deoxycytidine derivatives

Publications (1)

Publication Number Publication Date
ATE238335T1 true ATE238335T1 (de) 2003-05-15

Family

ID=26149007

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99907492T ATE238335T1 (de) 1998-02-06 1999-02-03 5' deoxycytidin-derivative

Country Status (19)

Country Link
US (1) US6005098A (de)
EP (1) EP1060183B1 (de)
JP (2) JP3625276B2 (de)
KR (1) KR100381516B1 (de)
CN (1) CN1260240C (de)
AR (1) AR014539A1 (de)
AT (1) ATE238335T1 (de)
AU (1) AU757136B2 (de)
BR (1) BR9907672A (de)
CA (1) CA2318848C (de)
CO (1) CO5070642A1 (de)
DE (1) DE69907161T2 (de)
DK (1) DK1060183T3 (de)
ES (1) ES2195543T3 (de)
MA (1) MA26606A1 (de)
PE (1) PE20000244A1 (de)
PT (1) PT1060183E (de)
TR (1) TR200002297T2 (de)
WO (1) WO1999040099A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119724A1 (en) * 1995-11-22 2003-06-26 Ts`O Paul O.P. Ligands to enhance cellular uptake of biomolecules
EP0882734B1 (de) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5-Deoxy-Cytidin-Derivate
DK1057831T3 (da) 1999-05-26 2005-01-31 Hoffmann La Roche Fremgangsmåde til fremstilling af vinylpyrimidinderivater
KR100631754B1 (ko) * 2000-08-09 2006-10-09 주식회사 코오롱 Ｎ-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법
WO2002043771A2 (en) 2000-12-01 2002-06-06 Cell Works Inc. Conjugates of glycosylated/galactosylated peptide
CN100383128C (zh) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 N4－氧羰基胞嘧啶衍生物及制备方法与应用
GB2442615A (en) * 2005-04-12 2008-04-09 Elan Pharma Int Ltd Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer
JP6866113B2 (ja) * 2016-11-01 2021-04-28 日本化薬株式会社 カペシタビンを有効成分とする医薬製剤
JP6792418B2 (ja) * 2016-11-08 2020-11-25 日本化薬株式会社 カペシタビンを有効成分とする医薬製剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
JPS54129131A (en) * 1978-03-27 1979-10-06 Taiho Pharmaceutical Co Ltd Antiimalignant tumor agent composition
US4328229A (en) * 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
CA1327358C (en) * 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
WO1992001452A1 (en) * 1990-07-19 1992-02-06 The Wellcome Foundation Limited Enzyme inactivators
GB9020930D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Pharmaceutical combinations
EP0543015B1 (de) * 1991-05-27 1998-11-11 Taiho Pharmaceutical Co., Ltd. Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren
TW254946B (de) * 1992-12-18 1995-08-21 Hoffmann La Roche
AU671491B2 (en) * 1992-12-18 1996-08-29 F. Hoffmann-La Roche Ag N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
EP0882734B1 (de) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5-Deoxy-Cytidin-Derivate

Also Published As

Publication number Publication date
CO5070642A1 (es) 2001-08-28
JP2004339230A (ja) 2004-12-02
PE20000244A1 (es) 2000-04-10
DK1060183T3 (da) 2003-08-11
WO1999040099A1 (en) 1999-08-12
KR100381516B1 (ko) 2003-04-23
KR20010072543A (ko) 2001-07-31
CA2318848A1 (en) 1999-08-12
EP1060183B1 (de) 2003-04-23
JP3625276B2 (ja) 2005-03-02
DE69907161D1 (de) 2003-05-28
ES2195543T3 (es) 2003-12-01
TR200002297T2 (tr) 2000-12-21
CA2318848C (en) 2008-09-02
AU2722799A (en) 1999-08-23
EP1060183A1 (de) 2000-12-20
AU757136B2 (en) 2003-02-06
BR9907672A (pt) 2000-11-28
JP2002502857A (ja) 2002-01-29
PT1060183E (pt) 2003-08-29
CN1290269A (zh) 2001-04-04
AR014539A1 (es) 2001-02-28
US6005098A (en) 1999-12-21
CN1260240C (zh) 2006-06-21
MA26606A1 (fr) 2004-12-20
DE69907161T2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO20010193D0 (no) Tiobenzimidazol-derivater
DK0930302T3 (da) Benzosulfonderivater
NO20010514D0 (no) Aminometylkarboksylsyre-derivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
PT1090019E (pt) Derivados de adenosina
ATE259810T1 (de) Phenyl-xanthinderivate
PT928790E (pt) Derivados de tiazolo
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
DK1140835T3 (da) 3,3-biarylpiperidin- og 2,2-biarylmorpholon-derivater
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
PT1056716E (pt) Derivados de ciclo-hexanodiolo
ATE233253T1 (de) Chromanderivate
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
DE69907161D1 (de) 5' deoxycytidin-derivative
EP1046648A4 (de) 3'-desoxyribonukleotid-derivate
EP1116726A4 (de) Ethylaminderivate
PT1123283E (pt) Derivados de tiazole
ATE243218T1 (de) 2''-deoxyhygromycinderivate
PT928793E (pt) Derivados de tiazol
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1060183

Country of ref document: EP

REN Ceased due to non-payment of the annual fee